NCT07526961 2026-04-14
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
Completed
Bristol-Myers Squibb
Bristol-Myers Squibb
Ankara Etlik City Hospital
Fujian Medical University
Gazi University
Bristol-Myers Squibb
University of Pittsburgh